2010•Journal of Cardiovascular Magnetic ResonanceOpen access

Endocardial extent by contrast enhanced cardiac magnetic resonance imaging is not an accurate method for assessing myocardium at risk; validation with T2-weighted cardiac magnetic resonance imaging

Joey F.A. Ubachs, Henrik Engblom, David Erlinge, Stefan V. Jovinge, Erik Hedström, Marcus Carlsson, Håkan Arheden

Open full text 0 citations

Abstract

In the situation of acute coronary occlusion, the myocardium supplied by the occluded vessel is subject to ischemia and is referred to as the myocardium at risk (MaR). It has previously been shown that cardiac magnetic resonance (CMR) imaging can be used for the assessment of MaR employing a T2-weighted edema sequence. Recently, it has been suggested that the endocardial extent of hyperenhancement as assessed by contrast enhanced CMR can also be used to quantify the MaR.

Open-access reader

About this research paper

What this paper is about

In the situation of acute coronary occlusion, the myocardium supplied by the occluded vessel is subject to ischemia and is referred to as the myocardium at risk (MaR). It has previously been shown that cardiac magnetic resonance (CMR) imaging can be used for the assessment of MaR employing a T2-weighted edema sequence. Recently, it has been suggested that the endocardial extent of hyperenhancement as assessed by contrast enhanced CMR can also be used to quantify the MaR.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

In the situation of acute coronary occlusion, the myocardium supplied by the occluded vessel is subject to ischemia and is referred to as the myocardium at risk (MaR). It has previously been shown that cardiac magnetic resonance (CMR) imaging can be used for the assessment of MaR employing a T2-weighted edema sequence. Recently, it has been suggested that the endocardial extent of hyperenhancement as assessed by contrast enhanced CMR can also be used to quantify the MaR.

Key concepts: Angiology, Medicine, Magnetic resonance imaging, Cardiac magnetic resonance, Cardiac magnetic resonance imaging, Cardiac imaging, Nuclear magnetic resonance, Cardiology

Related papers

Back to paper searchBrowse research topicsOriginal source
Endocardial extent by contrast enhanced cardiac magnetic resonance imaging is not an accurate method for assessing myocardium at risk; validation with T2-weighted cardiac magnetic resonance imaging — Research Paper | ScholarLens